Navigation Links
Despite Decline in Share of Global Output, U.S. Science Impact Still Strong, Says Thomson Reuters
Date:1/28/2009

PHILADELPHIA and LONDON, Jan. 28 /PRNewswire/ -- The Scientific business of Thomson Reuters today announced the results of a study showing that the United States' share of scientific research output continues to shrink while Asia-Pacific's share of output rises. Nevertheless, the U.S. retains a healthy footing globally in the relative impact of its research.

In its January/February issue of Science Watch, Thomson Reuters analyzes 12 year's worth of data from its National Science Indicators database to determine the U.S.'s global scientific influence based on the nation's research output and impact.

In 2005, Science Watch noted that the U.S.'s output, as a percentage of world science, was in decline, with Asia-Pacific's output steadily rising. This latest analysis shows the trends continuing. In 2005, the U.S. contributed 32.8 percent of global research; by 2007 its share slid to 31.5 percent. During the same period, Asia-Pacific's share increased from 25.9 percent to 28.2 percent.

"It is important to note that measuring scientific output is only one way to measure a country's influence in the sciences," said Christopher King, editor of Science Watch. "Because citations are an acknowledgement of intellectual debt, we also evaluate a country's citation impact. The U.S.'s citation impact has remained strong in the major science fields."

In all 21 science fields analyzed for this report, the U.S. markedly surpassed the world average in citation impact. Topping the list was Physics, where the U.S. exceeded the world mark by 55 percent, followed by Chemistry and Materials Science where the U.S. exceeded the world by 52 percent and 47 percent, respectively.

For more information about U.S. research output and impact, including expert analysis, visit ScienceWatch.com.

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 countries. For more information, go to www.thomsonreuters.com.


'/>"/>
SOURCE Thomson Reuters
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Fadel Partners Announces 13% Growth Despite IT Services Industry Downtrend
2. Despite Economic Woes, Physician Compensation Increases
3. Investment and Growth in US Medical Technology Industry Continues Despite Challenging Public Markets
4. Multigene Test Predicts Who Could Avoid Chemotherapy Despite Positive Lymph Nodes in Early Breast Cancer
5. Cell Therapeutics Net Loss Declines as Operating Expenses Decrease By 58% in Third Quarter 2008
6. Data show a decline in cystic fibrosis since introduction of prenatal carrier screening
7. Entry of Biogenerics and Decreasing Use of Amgens Epogen and Johnson & Johnsons Procrit Will Cause a $2.8 Billion Decline in the Drug Market for Chemotherapy-Induced Anemia by 2016
8. Progen Shareholders Call Meeting to Spill Progen Board and Offer Merger or Full Cash Back to Shareholders
9. Amgens Fourth Quarter 2008 Adjusted Earnings Per Share Increased 6 Percent to $1.06; Full Year 2008 Adjusted Earnings Per Share Increased 6 Percent to $4.55
10. IntraLinks Poll: Half of Clinical Trial Management Professionals Share Critical Information Via E-Mail
11. Cell Therapeutics, Inc. Provides Update on the Special Meeting of Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... LAKE CITY, UTAH. (PRWEB) , ... May 25, 2016 , ... ... efficiencies in healthcare information exchange, today announced that Charles W. Stellar has been named ... as WEDI’s interim CEO since January 2016. As an executive leader with more than ...
(Date:5/25/2016)... ... 25, 2016 , ... Biohaven Pharmaceutical Holding Company Ltd. (Biohaven) ... company’s orphan drug designation request covering BHV-4157 for the treatment of Spinocerebellar Ataxia ... , Spinocerebellar ataxia is a rare, debilitating neurodegenerative disorder that is estimated ...
(Date:5/24/2016)... , May 24, 2016   MedyMatch Technology Ltd ., ... artificial intelligence, real-time decision support tools in the emergency room, ... the 2016 Israeli Advanced Technology Industries (IATI) BioMed Conference. ... Israel,s 15th National Life Sciences and Technology Week, ... David Intercontinental Hotel in Tel Aviv, Israel ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... ... a newly re-branded identity. The new Media Cybernetics corporate branding reflects a results-driven ... of imaging and image analysis. The re-branding components include a crisp, refreshed logo ...
Breaking Biology Technology:
(Date:3/18/2016)... LONDON , March 18, 2016 ... Established Suppliers of Biometrics, ICT, Manned & Unmanned Vehicles, Physical ... & security companies in the border security market and ... and Europe has led ... your companies improved success. --> defence & ...
(Date:3/14/2016)... NXTD ) ("NXT-ID" or the "Company"), a company ... of a new series of commercials on Time Warner Cable ... .  The commercials will air on Bloomberg TV, Fox Business ... show. --> NXTD ) ("NXT-ID" or the "Company"), ... the airing of a new series of commercials on Time ...
(Date:3/10/2016)... , March 10, 2016 ... new market research report "Identity and Access Management Market ... Audit, Compliance, and Governance), by Organization Size, by Deployment, ... 2020", published by MarketsandMarkets, The market is estimated to ... 12.78 Billion by 2020, at a Compound Annual Growth ...
Breaking Biology News(10 mins):